MedTrace Logo

Robot-Assisted Ultrasound for Thermal Ablative Therapy in Treating Patients With Small Kidney Masses Undergoing Surgery

NCT02370342 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-12-20

No results posted yet for this study

Summary

This clinical trial studies a type of ultrasound called robot-assisted laparoscopic high-intensity focused ultrasound for performing thermal ablative therapy, or sound wave therapy, in treating patients with small kidney masses undergoing partial removal of the kidney. The robot-assisted ultrasound probe takes images of the kidney to help doctors locate the mass. The probe then uses high frequency sound waves to target and ablate (or destroy) the kidney mass, which may be a cancerous tumor or benign tissue. Surgery is then performed to remove the part of the kidney with the mass. Robot-assisted laparoscopic high-intensity focused ultrasound for thermal ablative therapy may be safer and help doctors see the tumor better when performing kidney surgery.

Conditions

  • Renal Carcinoma
  • Renal Mass

Interventions

PROCEDURE

Robot-Assisted Laparoscopic Surgery

Undergo robot-assisted laparoscopic HIFU ablation

PROCEDURE

High-Intensity Focused Ultrasound Ablation

Undergo robot-assisted laparoscopic HIFU ablation

PROCEDURE

Therapeutic Laparoscopic Surgery

Undergo laparoscopic partial nephrectomy

DEVICE

Sonatherm 600i Ultrasonic Lesion Generating System

Device used for high-intensity focused ultrasound ablation

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Southern California

    lead OTHER

Principal Investigators

  • Osamu Ukimura · University of Southern California

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-18
Primary Completion
2018-12-18
Completion
2019-12-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02370342 on ClinicalTrials.gov